Skip to content
OpenCapital
Get started

Charles River Laboratories CRL Foreign

Foreign at other companies

Plexus logo
PlexusPLXS
$7.49M+36.2%

Other financials

Income statement

See full
Revenue$995.8M+1.2%
Gross profit$349.0M-3.5%
Operating income$119.9M+60.6%
Net income-$14.8M-158%
EPS (diluted)-$0.30-160%

Balance sheet

See full
Cash & equivalents$198.2M-14.5%
Total debt$3.1B+1.9%
Total equity$2.9B-7.9%
Total assets$7.7B+2.0%

Cash flow

See full
Operating cash flow$41.1M-76.1%
CapEx$55.9M-5.8%
Free cash flow-$14.8M-113%

Valuation

See full
Market cap$8.91B+10.3%
Enterprise value$11.79B+8.5%
P/S2.2×+0.2×

Profitability

See full
Gross margin84.7%—
Operating margin13%-2.4pp
Net margin-4.6%—
FCF margin9.7%-4.3pp

Returns & leverage

See full
Return on equity-6%—
Debt / equity1×+0.1×
Current ratio1.4×-0.1×

Where this comes from

Reported directly by Charles River Laboratories in its filing.

Tagged under the XBRL concept us-gaap:CurrentForeignTaxExpenseBenefit.

The official record: Charles River Laboratories’s 10-K, filed February 18, 2026, on SEC EDGAR. View the filing →

Ask your AI about Charles River Laboratories's foreign.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Charles River Laboratories's foreign?
Charles River Laboratories (CRL) reported foreign of $24.36M in Q4 2025.
How has Charles River Laboratories's foreign changed year-over-year?
Charles River Laboratories's foreign increased by 12.6% year-over-year, from $21.62M to $24.36M.
What is the long-term trend for Charles River Laboratories's foreign?
Over 2 years (2023 to 2025), Charles River Laboratories's foreign has grown at a 6.8% compound annual growth rate (CAGR), from $85.36M to $97.43M.
What does foreign mean?
The current income tax expense or benefit incurred in foreign jurisdictions where the company operates. It captures the immediate tax obligations to international tax authorities.